Mary M. Tomayko - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Mary M. Tomayko's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Mary M. Tomayko
Verified
Editor-in-Chief, Dermatology Focus
Beats
Nothing is off limits.
Content
By Roy Jiang, Mary M. Tomayko, Xenofon Baraliakos, Qiongfei Zhou| ScienceDirect@ DC is entirely responsible for the content of this correspondence. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. DC performs consulting for Tonix Pharmaceuticals, Merck, UCB, Theravance, Teva, Virios, Vertex, and Axsome.
By William E. Damsky, Ramie Fathy, Devon E McMahon, Mary M. Tomayko| The Journal of Allergy & Clinical Immunology Verified To the Editor:1McMahon D.E. Amerson E. Rosenbach M. Lipoff J.B. Moustafa D. Tyagi A. et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol.
By Roy Jiang, Mary M. Tomayko, Xenofon Baraliakos, Qiongfei Zhou| ScienceDirect@ DC is entirely responsible for the content of this correspondence. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. DC performs consulting for Tonix Pharmaceuticals, Merck, UCB, Theravance, Teva, Virios, Vertex, and Axsome.
Company Info
Dermatology Focus